Rapid diagnostics of an floride infection by SARS-CoV-19 (COVID-19) using Ion Mobility Spectrometry for exhaled breath

• Conditions: COVID-19; U07.1; COVID-19, virus identified

• Registration Number: DRKS00024695
• Lead Sponsor: Helios Klinikum Aue

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-06
• Study Completion: 2021-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 927

Inclusion Criteria

Indikation gemäß Zielstellung
- Verdacht auf COVID-19
- Patient/Proband kommt in Abstrichstelle
- gesund bzw. frei von florider klinisch relevanter Infektion, aber mögliche Kontaktperson zu COVID-positiven Patienten (V.a. symptomlosen Träger) oder Einweisung mit Beschwerden

indication due to aim o the study,
suspicion of COVID-19
presentation in test unit
healthy or free of signs of infection
contact to COVID-19 cases
or typical symptoms for Covid

Exclusion Criteria

mechanical closure of both nasal sides

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary target of the study is to find and demonstrate rproducible cluster of volatile markers in IMS-spectra of exhaled breath and biological samples which are sufficient hints of a virale or bacterial infection.<br>

Secondary Outcome Measures

Name	Time	Method
surely exclusion of clinical relevant infection or absence of infective disease, resp., using exhaled markers.<br><br><br><br>